Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-02-25 @ 7:04 PM
Study NCT ID:
NCT00542594
Status:
TERMINATED
Last Update Posted:
2013-02-07
First Post:
2007-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
Sponsor:
AstraZeneca
Organization:
Study Overview
Official Title:
A Report Upon a Cohort of Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy for Hormone-dependant Breast Cancer. Long-term Tolerance Evaluation
Status:
TERMINATED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
No results are avaialble as the study did not complete according to the protocol
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARIES
Brief Summary:
The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: